Real-world experience with the IUB Ballerine MIDI copper IUD: an observational, single-centre study in Israel

被引:3
|
作者
Baram, Ilan [1 ,2 ]
Aharon, Arnon [2 ]
Klein, Rinat [2 ]
Shkolnik, Ketty [2 ]
机构
[1] Maccabi Healthcare Serv, Modiin, Israel
[2] OCON Healthcare, Clin Dev, Modiin, Israel
关键词
Contraceptive; IUB; IUB Ballerine MIDI; IUD; LARC; UNINTENDED PREGNANCY; CONTRACEPTIVE METHODS; INTRAUTERINE-DEVICE; UNITED-STATES; EFFICACY;
D O I
10.1080/13625187.2019.1699048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: The aim of the study was to assess the acceptability of the intrauterine ball IUB Ballerine MIDI copper intrauterine device (IUD), using real-world data collected from users and physicians in Israel. Methods: In this retrospective, observational study, conducted in a single clinic in Israel, healthy women (n = 175) who had had the device inserted >= 12 months prior to enrolment, and their physician, completed questionnaires relating to device insertion, user experience and performance. Results: The mean age at insertion was 32.8 +/- 6.7 years; most women were married (80.6%) and multigravid (89.1%). At the time of the study, 131 (74.9%) women were still using the device; in 13 cases (7.4%), premature removal was due to desire to conceive. The 12 month continuation rate, excluding the women seeking to conceive, was 90.1%. The expulsion rate was 3.4% (n = 6) and the pregnancy rate was 0.57% (n = 1). Most of the women still using the device reported no to moderate pain or cramps (90.0%) and moderate to high (72.6%) satisfaction with the device; 76.3% said they would recommend it to friends and relatives. Most of the insertion procedures (86.9%) were uneventful and none required cervical dilation. Conclusion: The IUB Ballerine MIDI raised no major safety concerns and was both effective and highly accepted in a cohort of women, covering a broad age range, treated in a gynaecology clinic in Israel.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [21] Diagnosing autoimmune encephalitis in a real-world single-centre setting
    Antonino Giordano
    Raffaella Fazio
    Stefano Gelibter
    Fabio Minicucci
    Marco Vabanesi
    Nicoletta Anzalone
    Giuseppe Magnani
    Massimo Filippi
    Vittorio Martinelli
    Journal of Neurology, 2020, 267 : 449 - 460
  • [22] Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
    Chowdhury, Sharmistha Roy
    Sadouki, Fethi
    Collins, Edward
    Keen, Frederick
    Bhagi, Ridhi
    Lim, Yuan S. J.
    Cozma, Silviu L.
    Bain, Stephen C.
    DIABETES THERAPY, 2024, 15 (04) : 869 - 881
  • [23] Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study
    Sharmistha Roy Chowdhury
    Fethi Sadouki
    Edward Collins
    Frederick Keen
    Ridhi Bhagi
    Yuan S. J. Lim
    Silviu L. Cozma
    Stephen C. Bain
    Diabetes Therapy, 2024, 15 : 869 - 881
  • [24] Convergent ablation for persistent atrial fibrillation: outcomes from a single-centre real-world experience
    Mannakkara, Nilanka N.
    Porter, Bradley
    Child, Nicholas
    Sidhu, Baldeep S.
    Mehta, Vishal S.
    Elliott, Mark K.
    Gould, Justin
    Ahmed, Shahada
    Razavi, Reza
    Rinaldi, Christopher A.
    Blauth, Christopher
    Gill, Jaswinder S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 63 (01)
  • [25] Real-World Outcome of Dose-Adjusted EPOCH-R, a Single-Centre Experience
    Wong, Rachel
    Kansara, Roopesh R.
    BLOOD, 2020, 136
  • [26] Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience
    Tse, Brandon
    Buchholz, Megan
    Pavenski, Katerina
    PLATELETS, 2023, 34 (01)
  • [27] Aortic versus axillary artery cannulation for hemiarch replacement: single-centre real-world experience
    Ustunisik, Cigdem Tel
    Yagci, Lara
    Arapi, Berk
    Balkanay, Ozan Onur
    Omeroglu, Suat Nail
    Ipek, Gokhan
    Goksedef, Deniz
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [28] Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study
    Gonzalez Mazario, Roxana
    Fragio Gil, Jorge Juan
    Ivorra Cortes, Jose
    Grau Garcia, Elena
    Canada Martinez, Antonio Jose
    Puig, Luis Gonzalez
    Negueroles Albuixech, Rosa Maria
    Roman Ivorra, Jose Andres
    REUMATOLOGIA CLINICA, 2022, 18 (09): : 523 - 530
  • [29] A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
    Bose, Gauruv
    Rush, Carolina
    Atkins, Harold L.
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [30] Flash glucose monitoring (FGM) in people with Type 1 diabetes: Single-centre real-world experience
    Abdalaziz, A.
    Lan, K.
    Bilous, M.
    Winship, S.
    Aldibbiat, A.
    DIABETIC MEDICINE, 2018, 35 : 168 - 168